Jade Biosciences (JBIO) Capital Expenditures (2021 - 2025)
Jade Biosciences (JBIO) posted Capital Expenditures of -$155000.0 for Q4 2025, down 155.16% on a QoQ basis from $281000.0 in Q3 2025, and down 168.58% year-over-year from $226000.0 in Q4 2024.
Jade Biosciences (JBIO) Capital Expenditures (2021 - 2025) Analysis & Trends
Jade Biosciences' Capital Expenditures history runs 5 years deep, the most recent figure standing at -$155000.0 for Q4 2025.
- Quarterly Capital Expenditures fell 168.58% year-over-year to -$155000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $38000.0 (up 106.75% YoY) and the FY2025 annual result came in at $38000.0, up 106.75% from the prior year.
- Capital Expenditures was -$155000.0 for Q4 2025 at Jade Biosciences, down from $281000.0 in the prior quarter.
- Across five years, Capital Expenditures topped out at $1.7 million in Q3 2024 and bottomed at -$2.5 million in Q2 2024.
- A 5-year average of $77789.5 and a median of $28000.0 in 2022 frame the typical range for Capital Expenditures.
- Annual changes were most pronounced in 2022 — Capital Expenditures jumped 13030.77% — and 2024, when it tumbled 15775.0%.
- Jade Biosciences' Capital Expenditures stood at -$13000.0 in 2021, then soared by 13030.77% to $1.7 million in 2022, then plunged by 98.1% to $32000.0 in 2023, then jumped by 606.25% to $226000.0 in 2024, then plunged by 168.58% to -$155000.0 in 2025.
- Business Quant data shows JBIO's Capital Expenditures at -$155000.0 in Q4 2025, $281000.0 in Q3 2025, and -$28000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -8,939.03 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 43.25 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 133.40 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 230.60 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 786,000.00 |
| 10 | Jade Biosciences | 16.25 Mn | 16.25 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -155,000.00 |
| Dec 31, 2025 | -155,000.00 |
| Sep 30, 2025 | 281,000.00 |
| Sep 30, 2025 | 281,000.00 |
| Jun 30, 2025 | -28,000.00 |
| Jun 30, 2025 | -28,000.00 |
| Mar 31, 2025 | -60,000.00 |
| Mar 31, 2025 | -60,000.00 |
| Dec 31, 2024 | 226,000.00 |
| Dec 31, 2024 | 226,000.00 |
| Sep 30, 2024 | 1.72 Mn |
| Sep 30, 2024 | 1.72 Mn |
| Jun 30, 2024 | -2.51 Mn |
| Jun 30, 2024 | -2.51 Mn |
| Mar 31, 2024 | -2,000.00 |
| Mar 31, 2024 | -2,000.00 |
| Dec 31, 2023 | 32,000.00 |
| Dec 31, 2023 | 32,000.00 |
| Sep 30, 2023 | 32,000.00 |
| Sep 30, 2023 | 32,000.00 |